PPARA and early-onset autosomal dominant Alzheimer disease: Their potential for the treatment of Alzheimer’s disease is based on the ability of the plant extract to activate PPAR-α (peroxisome proliferator-activated receptor alpha) and PPAR-γ (peroxisome proliferator-activated receptor gamma) selectively [41].